查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2016994

遠端保健市場：按組件、存取類型、應用和最終用戶分類－2026-2032年全球市場預測

Telehealth Market by Component, Mode of Access, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，遠端保健市場價值將達到 624.3 億美元，到 2026 年將成長至 739.6 億美元，到 2032 年將達到 2012.8 億美元，複合年成長率為 18.20%。

主要市場統計數據
基準年 2025 624.3億美元
預計年份：2026年 739.6億美元
預測年份 2032 2012.8億美元
複合年成長率 (%) 18.20%

全面概述患者行為、技術進步和監管變化如何共同重新定義虛擬護理工作流程和交付模式。

在不斷變化的患者期​​望、臨床技術的進步以及日益完善的法規環境的推動下，遠端保健已從輔助管道發展成為醫療服務的核心要素。隨著寬頻存取的改善、遠端監測設備的日益先進以及消費者對數位互動接受度的提高，虛擬醫療的範圍正從一次性就診擴展到持續的慢性病管理和急性分診。臨床醫生正在重塑醫療模式，將虛擬就診點納入其工作流程，不再將其視為例外，而是作為標準組成部分。

這是一個重要的結構和營運轉折點，將孤立的虛擬諮詢轉變為連續的、全面的、以結果為導向的醫療保健服務體系。

在遠端醫療領域，多項變革正在同步發生，重塑著策略重點。首先，醫療服務模式正從以諮詢為中心的模式轉向以數據驅動的持續性醫療編配，這種模式依賴於遠距監測、非同步通訊和整合式診療路徑來改善治療效果並減少摩擦。這種轉變需要對後端編配層和新的臨床協議進行投資，以確保虛擬診療和線下診療之間安全可靠的升級和交接。

2025 年的利率變化和貿易政策的轉變將如何重塑遠距醫療籌資策略、醫療設備採購以及整個醫療保健連續體中的區域遠端保健夥伴關係？

近期關稅調整和2025年推出的貿易政策措施對遠端保健系統內的零件採購、醫療設備採購以及國際供應商關係產生了重大影響。依賴全球化供應鏈的醫療設備製造商面臨投入成本上升導致利潤空間受擠壓，迫使他們重新評估供應商合約。為此，許多機構加快了供應商多元化進程，並增加了庫存緩衝，以確保醫療設備的持續供應，並按計劃推進遠端監測舉措。

透過進行關鍵的細分分析，揭示不同臨床環境和治療領域的不同實施路徑，可以實現有針對性的投資和專案設計。

終端用戶的採用模式清晰地表明了遠距醫療走向規模化和整合的路徑。診所優先考慮遠端保健，以延長諮詢時間和進行後續護理管理；診斷中心則整合遠距醫療，以加快分診速度並減少無故缺席。居家照護機構利用遠距監測和虛擬諮詢來提高轉運過程中的安全性並降低再入院風險；醫院則將遠端保健整合到急診和專科工作流程中，以拓展專科診療範圍。患者本身也越來越受益於使用者友善的介面，並開始使用虛擬醫療服務來獲得便利、慢性病管理和心理健康服務，這催生了對跨醫療機構無縫銜接的病人歷程的需求。

區域比較分析概述了不同的法規環境、支付方結構和基礎設施環境如何影響遠端保健部署策略。

在美洲，遠距醫療的普及主要由支付主導的試點計畫、雇主支持的虛擬醫療計畫以及醫療服務提供者之間的緊密合作網路所推動。在該市場，報銷創新、企業合約和患者體驗是擴大規模的關鍵促進因素。在歐洲、中東和非洲，管理體制和基礎設施成熟度各不相同，有些地區擁有先進的國家級遠端保健框架，而有些地區仍然缺乏網路連接和支付管道。與當地衛生部門建立策略夥伴關係以及擴充性的低頻寬解決方案可以加速遠距醫療的普及。在亞太地區，以行動優先的人口結構和私營部門對數位醫療的大量投資推動了城市地區的快速普及。然而，都市區地區網路連結的差異和監管的碎片化使得需要採用適應性強的服務模式和本地夥伴關係才能實現更廣泛的普及。

平台供應商、設備製造商和醫療保健提供者投資於策略行動和能力建設，以在虛擬醫療領域創造永續的競爭優勢。

在整個生態系統中，各公司正致力於應對一系列策略挑戰，以維持差異化優勢。許多平台供應商正在投資更深入的臨床整合和模組化API，以實現與電子健康記錄和人群健康管理工具的互通性。醫療設備製造商優先考慮安全韌體、標準化資料格式和服務等級保障，以支援臨床級遙測技術。醫療服務提供者正與科技公司合作，共同開發診療路徑，通常專注於慢性病打包診療或專科虛擬診所。此外，一些機構正優先建構證據組合，包括真實世界結果研究和實施科學，以證明臨床療效並支持與保險公司和監管機構的討論。

經營團隊，以擴大遠距遠端保健的覆蓋範圍，確保臨床安全，並最佳化營運績效。

領導者應優先考慮互通性和數據標準化，以確保遠端保健互動能夠反映在長期照護記錄和分析平台中。投資於以臨床醫生為中心的設計和系統化的變革管理，可以減少摩擦並促進永續使用。籌資策略應強調模組化契約，將硬體、軟體和服務分開，以確保定價柔軟性並降低供應鏈風險。各機構還應制定循證計劃，量化臨床和營運影響，同時積極與保險公司和監管機構合作，就結果指標和報銷途徑達成協議。

對混合方法研究設計、主要和次要來源以及檢驗過程進行詳細解釋，以得出實用見解和建議。

本報告採用混合方法進行分析，結合了對關鍵相關人員的訪談、與臨床專家的諮詢以及對政策文件和已發表臨床研究的系統性回顧。主要資訊來源是與醫療機構高階主管、採購經理和技術架構師的結構化對話，這些對話深入了解了實際部署挑戰和商業性趨勢。輔助研究包括對監管趨勢、技術標準和已發表的成果研究的評估，以補充這些發現並確保與最新證據保持一致。

將營運重點、監管合作和證據產生與綜合虛擬醫療計畫的長期成功連結起來的決定性整合。

遠端醫療不再是實驗性工具，而是必須融入醫療機構核心營運模式的策略性功能。其成功取決於技術選擇與臨床工作流程的契合度、採購系統的建立以及供應鏈風險的管理，並透過結果和體驗指標來展現其價值。監管環境和支付方環境將持續演變。積極與相關人員互動並建構適應性強、以實證醫學為基礎的計畫的機構，最能充分利用虛擬醫療帶來的臨床和營運效益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：遠端保健市場：按組成部分分類

  • 硬體
  • 軟體和服務

第9章：遠端保健市場進入方法

  • 整合系統
  • 行動應用
  • 僅限電話/語音
  • 網路為基礎的平台

第10章：遠端保健市場：依應用領域分類

  • 循環系統
  • 神經病學
  • 腫瘤學
  • 精神病學

第11章遠端保健市場：按最終用戶分類

  • 診所
  • 診斷中心
  • 居家照護
  • 醫院
  • 病人

第12章遠端保健市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：遠端保健市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章遠端保健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國遠端保健市場

第16章：中國遠端保健市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 20now, Inc.
  • 3Derm Systems, Inc.
  • 98point6, Inc.
  • A&D Medical, Inc.
  • Aemtec GmbH
  • Aerotel Medical Systems Ltd.
  • Agnity, Inc.
  • AMC Health, LLC
  • AMD Global Telemedicine, Inc.
  • American Well Corporation
  • Arizona Telemedicine Program
  • Arkansas e-Link
  • Babylon Health Limited
  • Cisco Systems, Inc.
  • DeliverHealth Solutions LLC
  • Doximity, Inc.
  • HealthTap, Inc.
  • Koninklijke Philips NV
  • MDLive, Inc.
  • Medtronic plc
  • MeMD, Inc.
  • PlushCare, Inc.
  • Teladoc Health, Inc.
Product Code: MRR-030298DFF6A2

The Telehealth Market was valued at USD 62.43 billion in 2025 and is projected to grow to USD 73.96 billion in 2026, with a CAGR of 18.20%, reaching USD 201.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 62.43 billion
Estimated Year [2026] USD 73.96 billion
Forecast Year [2032] USD 201.28 billion
CAGR (%) 18.20%

A comprehensive orientation to how patient behavior, technological advances, and regulatory change are collectively redefining virtual care workflows and delivery models

Telehealth has evolved from an auxiliary channel into a core element of care delivery, propelled by sustained shifts in patient expectations, advances in clinical technologies, and an increasingly supportive regulatory environment. The convergence of improved broadband access, more capable remote monitoring devices, and higher consumer comfort with digital interactions has expanded the scope of virtual care beyond episodic visits to ongoing chronic condition management and acute triage pathways. Clinicians are reconfiguring care models to incorporate virtual touchpoints as standard workflow components rather than exceptions.

Against this backdrop, the health workforce is adapting to new modalities of practice with an emphasis on digital literacy, remote diagnostics, and team-based virtual care. Payers and employers are experimenting with novel reimbursement constructs and value-based approaches that reward outcomes delivered through hybrid care models. In parallel, technology vendors are maturing platform capabilities to address interoperability, security, and user experience, which are essential to clinician adoption and patient retention. The result is a more resilient, accessible, and outcome-focused telehealth landscape that demands strategic planning from providers, payers, and vendors alike.

Key structural and operational inflection points that are converting episodic virtual visits into continuous, integrated, outcome-focused care delivery systems

The telehealth landscape is undergoing several concurrent shifts that are reshaping strategic priorities. First, care delivery is moving from visit-centric models toward continuous, data-driven care orchestrations that rely on remote monitoring, asynchronous messaging, and integrated care pathways to improve outcomes and reduce friction. This transition requires investment in backend orchestration layers and new clinical protocols to ensure safe escalation and handoffs between virtual and in-person care.

Second, technology architectures are transitioning from point solutions toward platform approaches that integrate clinical systems, patient engagement tools, and device telemetry. This consolidation increases the premium on interoperability standards, data governance, and user-centered design. Third, regulatory regimes are evolving to balance access with quality, prompting organizations to invest in compliance frameworks and to engage proactively with payers to secure sustainable reimbursement. Finally, workforce models are changing: clinical teams are blending virtual and in-person roles, and organizations that prioritize clinician experience, training, and clear performance metrics are achieving higher utilization and patient satisfaction rates. Together, these shifts require an integrated strategy that aligns technology investment, clinical change management, and stakeholder engagement.

How 2025 tariff adjustments and trade policy shifts are reshaping telehealth procurement strategies, device sourcing, and partnership geographies across the care continuum

Recent tariff adjustments and trade policy measures introduced in 2025 have had a material effect on component sourcing, device procurement, and international vendor relationships within the telehealth ecosystem. Device manufacturers that rely on globalized supply chains experienced increases in input costs that pressured margins and necessitated re-evaluation of vendor contracts. In response, many organizations accelerated diversification of suppliers and increased inventory buffers to maintain continuity of care device availability and to protect deployment timelines for remote monitoring initiatives.

At the same time, software platform vendors that embed specialized hardware into bundled offerings revisited pricing and commercial models, driving procurement teams to negotiate more granular contractual terms that separate hardware from software services. Healthcare providers and health systems also adjusted capital planning assumptions for large-scale device rollouts, prioritizing interoperable solutions that can leverage domestically produced components or that enable phased procurement to mitigate tariff exposure. Lastly, trade policy changes have influenced partnership geography, prompting strategic assessments of nearshoring and regional vendor hubs to reduce exposure to cross-border tariff volatility and to shorten lead times for critical clinical devices.

Critical segmentation intelligence revealing differentiated adoption pathways across clinical settings and therapeutic areas that inform targeted investment and program design

End-user adoption patterns reveal distinct pathways for scale and integration. Clinics are prioritizing telehealth to extend clinic hours and manage follow-up care, whereas diagnostic centers are integrating teleconsultations to speed triage and reduce no-shows. Home care providers are using remote monitoring and virtual visits to enhance safety during transitions and to lower readmission risk, while hospitals are embedding telehealth into emergency and specialty workflows to extend specialist reach. Patients themselves, increasingly empowered by consumer-friendly interfaces, are using virtual care for convenience, chronic care management, and behavioral health access, creating demand for seamless patient journeys that bridge settings.

Application-level dynamics show differential maturity and clinical complexity. Cardiology applications are centered on long-term rhythm monitoring, hypertension management, and post-procedural follow-up supported by high-fidelity telemetry. Neurology virtual care is advancing through remote assessments, seizure monitoring, and rehabilitation support that leverage wearable sensor data and tele-rehabilitation platforms. Oncology telehealth is enhancing patient navigation, symptom management, and multidisciplinary tumor board coordination without replacing the need for in-person infusion and complex procedures. Psychiatry continues to be one of the most widely adopted telehealth applications, driven by comparatively lower diagnostic equipment needs and high patient demand for accessible behavioral health services. These segmentation insights highlight where organizational investments in workflow redesign, clinician training, and platform capabilities will likely yield the greatest clinical and operational returns.

Comparative regional intelligence outlining how distinct regulatory environments, payer structures, and infrastructure profiles shape telehealth deployment strategies

The Americas continue to drive adoption through payer-led pilots, employer-sponsored virtual care programs, and a dense network of provider integrations; the market emphasizes reimbursement innovation, enterprise contracting, and patient experience as primary levers for scale. Europe, Middle East & Africa exhibit heterogeneous regulatory regimes and infrastructure maturity, with pockets of advanced national telehealth frameworks juxtaposed against areas where connectivity and payment pathways remain nascent; strategic partnerships with regional health authorities and scalable, low-bandwidth solutions can accelerate reach. Asia-Pacific demonstrates rapid uptake in urban centers, supported by mobile-first populations and high private-sector investment in digital health, while disparities in rural connectivity and regulatory fragmentation require adaptable delivery models and local partnerships to unlock broad reach.

Understanding these regional differences is essential for tailoring product features, commercial models, and implementation support. Organizations that sequence market entry based on regulatory clarity, reimbursement pathways, and partner ecosystems are better positioned to deploy repeatable programs and to adapt quickly as national policies evolve.

Strategic behaviors and capability investments among platform vendors, device makers, and provider organizations that create sustainable competitive differentiation in virtual care

Across the ecosystem, companies are converging on a set of strategic imperatives to maintain differentiation. Many platform vendors are deepening their clinical integrations and investing in modular APIs to enable interoperability with electronic health records and population health tools. Device manufacturers are emphasizing secure firmware, standardized data formats, and service-level commitments to support clinical-grade telemetry. Providers are forming partnerships with technology firms to co-develop care pathways, often focusing on chronic disease bundles and specialty virtual clinics. In addition, several organizations have prioritized building evidence portfolios-including real-world outcome studies and implementation science-to demonstrate clinical effectiveness and to support discussions with payers and regulators.

Competitive advantage increasingly depends on the ability to operationalize virtual care at scale: seamless clinician workflows, measurable clinical outcomes, and transparent economics. Firms that combine robust clinical workflows, strong security and compliance postures, and flexible commercial models are best positioned to win long-term enterprise relationships and to support population health initiatives across payers and providers.

Practical and prioritized strategic imperatives that executive teams can implement immediately to expand telehealth reach, secure clinical safety, and optimize operational performance

Leaders should prioritize interoperability and data standards to ensure that telehealth interactions feed reliably into longitudinal care records and analytics platforms. Investing in clinician-centered design and structured change management will reduce friction and increase sustained utilization. Procurement strategies should emphasize modular contracting that separates hardware, software, and services to allow pricing flexibility and to mitigate supply chain risk. Organizations must also engage proactively with payers and regulators to align on outcome measures and reimbursement pathways, while developing evidence-generation plans that quantify clinical and operational impacts.

Operationally, scale requires clear escalation protocols, standardized virtual visit documentation, and performance metrics that tie virtual care activity to clinical outcomes. Workforce strategies should include training, workload design, and incentives that reflect blended virtual and in-person responsibilities. Finally, risk management must cover data security, privacy, and vendor resilience planning; scenario-based stress testing of supply chains and continuity plans will protect program uptime and patient safety. Implementing these recommendations will enable organizations to move from pilot success to enduring, value-driven programs.

Detailed explanation of the mixed-methods research design, primary and secondary data sources, and validation processes used to derive actionable insights and recommendations

The analysis underpinning this report was developed through a mixed-methods approach that combined primary stakeholder interviews, expert clinician consultations, and systematic review of policy documents and published clinical studies. Primary inputs included structured conversations with provider executives, procurement leaders, and technology architects to capture real-world implementation challenges and commercial dynamics. Secondary research complemented these insights with an assessment of regulatory developments, technology standards, and published outcome studies to ensure alignment with current evidence.

Findings were triangulated across data sources to enhance robustness, and methodological limitations were acknowledged where evidence was emerging or uneven across regions. The synthesis prioritized themes that demonstrated both practical applicability and empirical support, and recommendations were stress-tested against plausible operational scenarios. This approach ensures that the report's conclusions are grounded in a combination of practitioner experience and documented trends, enabling leaders to make informed strategic choices while recognizing areas that require ongoing evidence generation.

Conclusive synthesis linking operational priorities, regulatory engagement, and evidence generation to the long-term success of integrated virtual care programs

Telehealth is no longer an experimental channel but a strategic capability that must be integrated into the core operating model of healthcare organizations. Success depends on aligning technology choices with clinical workflows, structuring procurement to manage supply chain risks, and demonstrating value through outcomes and experience metrics. Regulatory and payer landscapes will continue to evolve, and organizations that proactively engage stakeholders and build adaptable, evidence-backed programs will be best positioned to capture the clinical and operational benefits of virtual care.

Looking ahead, leaders should balance immediate operational needs-such as clinician training and interoperability-with medium-term investments in platform resilience and outcome measurement. By doing so, organizations can unlock sustained improvements in access, patient experience, and care continuity across clinical settings and therapeutic areas.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Telehealth Market, by Component

  • 8.1. Hardware
  • 8.2. Software & Services

9. Telehealth Market, by Mode of Access

  • 9.1. Integrated Systems
  • 9.2. Mobile Apps
  • 9.3. Telephonic / Voice Only
  • 9.4. Web-Based Platforms

10. Telehealth Market, by Application

  • 10.1. Cardiology
  • 10.2. Neurology
  • 10.3. Oncology
  • 10.4. Psychiatry

11. Telehealth Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Home Care
  • 11.4. Hospitals
  • 11.5. Patients

12. Telehealth Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Telehealth Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Telehealth Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Telehealth Market

16. China Telehealth Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 20now, Inc.
  • 17.6. 3Derm Systems, Inc.
  • 17.7. 98point6, Inc.
  • 17.8. A&D Medical, Inc.
  • 17.9. Aemtec GmbH
  • 17.10. Aerotel Medical Systems Ltd.
  • 17.11. Agnity, Inc.
  • 17.12. AMC Health, LLC
  • 17.13. AMD Global Telemedicine, Inc.
  • 17.14. American Well Corporation
  • 17.15. Arizona Telemedicine Program
  • 17.16. Arkansas e-Link
  • 17.17. Babylon Health Limited
  • 17.18. Cisco Systems, Inc.
  • 17.19. DeliverHealth Solutions LLC
  • 17.20. Doximity, Inc.
  • 17.21. HealthTap, Inc.
  • 17.22. Koninklijke Philips N.V.
  • 17.23. MDLive, Inc.
  • 17.24. Medtronic plc
  • 17.25. MeMD, Inc.
  • 17.26. PlushCare, Inc.
  • 17.27. Teladoc Health, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TELEHEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TELEHEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TELEHEALTH MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TELEHEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TELEHEALTH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TELEHEALTH MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TELEHEALTH MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TELEHEALTH MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TELEHEALTH MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TELEHEALTH MARKET SIZE, BY TELEPHONIC / VOICE ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TELEHEALTH MARKET SIZE, BY WEB-BASED PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TELEHEALTH MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TELEHEALTH MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TELEHEALTH MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TELEHEALTH MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TELEHEALTH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TELEHEALTH MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TELEHEALTH MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TELEHEALTH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TELEHEALTH MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TELEHEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS TELEHEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TELEHEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. ASEAN TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. GCC TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GCC TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. GCC TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. GCC TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. G7 TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. G7 TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 115. G7 TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 116. G7 TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. G7 TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NATO TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NATO TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 120. NATO TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 121. NATO TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TELEHEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA TELEHEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA TELEHEALTH MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 131. CHINA TELEHEALTH MARKET SIZE, BY MODE OF ACCESS, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA TELEHEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA TELEHEALTH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)